Biomarkers for efficacy of aliskiren as a hypertensive agent

Details for Australian Patent Application No. 2006227283 (hide)

Owner Novartis AG

Inventors Gu, Jessie; Meyer, Joanne

Agent Davies Collison Cave

Pub. Number AU-B-2006227283

PCT Pub. Number WO2006/102177

Priority 60/742,401 06.02.06 US; 60/664,248 22.03.05 US

Filing date 20 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 1 July 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102177 Priority application(s): WO2006/102177

1 July 2010 Application Accepted

  Published as AU-B-2006227283

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227295-A reactor system and process for the manufacture of ethylene oxide

2006227274-Methods and apparatus for pumping and dispensing